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Abstract
The reliable and timely stratification of bone lesion evolution risk in smoldering Multiple
Myeloma plays an important role in identifying prime markers of the disease’s advance
and in improving the patients’ outcome. In this work we provide an asymmetric cascade
network for the longitudinal prediction of future bone lesions for T1 weighted whole body
MR images. The proposed cascaded architecture, consisting of two distinct configured U-
Nets, first detects the bone regions and subsequently predicts lesions within bones in a patch
based way. The algorithm provides a full volumetric risk score map for the identification of
early signatures of emerging lesions and for visualising high risk locations. The prediction
accuracy is evaluated on a longitudinal dataset of 63 multiple myeloma patients.
Keywords: Longitudinal prediction, asymmetric cascade U-Net, Multiple Myeloma, bone
lesion assessment
1. Introduction
A key component in assessing the progression status of Multiple Myeloma (MM) is the
identification of prime markers of the disease’s advance during its prestage (smoldering
Multiple Myeloma (sMM)). sMM is the most common disorder that leads to the malignant
transformation of plasma cells and B-lymphocytes and in symptomatic MM to myeloma
cells (Tosi). These further interact with bone marrow cells, which trigger the osteoclasts’
activity, enhances bone resorption, and inhibits osteoblasts. Consequently, this leads from
bone infiltration to destruction. Diffuse or focal bone infiltration starting during sMM are
routinely imaged using whole body (wb) MRI (T1, T2) (Dimopoulos et al., 2015; Merz et al.,
c© 2019 R. Licandro et al.
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Figure 1: Framework proposed for mapping future lesion risk in a whole body MRI
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2014; Kloth et al., 2014), while the gold standard to asses osseous destructions in late disease
states is low-dose Computer Tomography (CT) (Lambert et al., 2017). The contribution
of existing machine learning approaches lies in the detection of bone lesions. U-Nets have
shown great potential in segmenting 2D microscopic images (Ronneberger et al., 2015), in
detecting brain lesions (Kamnitsas et al., 2016) or bone lesions. In (Perkonigg et al., 2018)
transfer learning is used to classify bone lesions in CT scans of MM patients. Our work was
inspired by (Christ et al., 2017), where a cascade of two fully convolutional networks showed
promising results for segmenting liver lesions in CT, by dividing the detection task in liver
extraction and lesion detection within the liver region. Here, a method for the prediction of
a bone lesion’s future evolution risk in wbMRI is presented. This work provides the basis
for effective treatment planning and response assessment during early MM stages, which
shows a clear benefit for patients (Mateos et al., 2016). To our knowledge our method is the
first approach providing a segmentation routine for bones in T1 wbMRI and also the first to
perform longitudinal prediction of bone lesions in wbMRI using deep network architectures.
2. Contribution
The pipeline proposed consists of an asymmetric cascade of two U-Nets. Asymmetric,
since a slice-based and patch-based U-Net (Fig. 1) are concatenated for slice-based bone
segmentation (BoneNet - BN ) and patch-based (LesionNet - LN ) lesion prediction. Both
U-Net architectures are based on (Ronneberger et al., 2015), but with exponential linear
units in the convolution layers, Adam optimizer and a sigmoid function for the output. The
proposed nets vary in terms of the dimensions of the layers and the loss function, where BN
uses binary cross entropy (BCE) and LN a weighted BCE loss to overcome the imbalance
between amount of lesion and non-lesion pixels. The BN’s input is a 2D wbMRI slice (size
384× 384 pixels) and the output a bone map. The LN’s input are image patches extracted
within the bone region of size 64×64 pixels (7k - 10k patches per slice, ∼200k per volume (30
slices)) and the output are patch-based lesion predictions which are further reconstructed
to a full volume risk map. The longitudinal data used for training is preprocessed by first
performing bias field correction and subsequently aligning follow-up images (It,It+1) of a
patient by affine and non-rigid registration (Modat et al., 2014). The BN is trained using the
dataset Bone:{Ipt , Bpt }, which consists of a patient’s p images and corresponding bone masks
B = B1t , . . . , B
M
t . The dataset Lesion:{Ipt , Spt+1} for training the LN are pairs consisting
of an aligned intensity image of a subject at time point t and aligned lesion annotations A
of the subsequent time point t + 1. The intensity images in Lesion are cropped using the
corresponding thresholded (0.5) and dilated (2 pixels) bone maps Bti , which are also used
to create patches out of the bone region with a sliding window approach.
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Figure 2: Example of bone segmentation and lesion prediction results.
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3. Results
The algorithm is evaluated on a data set of 220 longitudinal wbMRIs of 63 MM patients
with overall 170 lesions. The data was acquired following (Durie et al., 2003) between 2004
and 2011. Bone and lesion annotations are provided by medical experts for every volume.
In all experiments leave-one-out cross validation was used. We evaluated emerging lesions
(non annotated in the input image but in the future state), for the thoracic/abdominal
body part (BPthorax) and in the pelvic/extremities body part (BPlegs). In the extremities’
region a higher bone segmentation performance is achieved with a mean Area under the
ROC (AUC) of 0.8023. Bone lesions are predicted with a mean AUC between 0.6083
(BPthorax) and 0.5304 (BPlegs). The mapping of bone lesions in the future is a challenging
task, since bone anomalies (not evolving towards lesions) can trigger false positives, while
false negatives suggest weak early signatures. However, results show that the predicted risk
score is capable of capturing early signatures of emerging lesions also illustrated in Figure 2.
Here, a qualitative result for focal lesion prediction in BPlegs is shown (from left to right):
(1) input image I at timepoint t, (2) detected bone mask (3) predicted lesion risk map
(red=high risk, blue = low risk) (4) detailed view on the risk map and target image in an
anomaly region (1st row) and lesion region (2nd row), (5) manual future lesion annotations
(cyan) and corresponding target image at timepoint t + 1 (3 years later). The risk map at
the distal part of the left femur visualises a high risk, which draws correspondence with the
annotations of the future state. At the right distal femur, the proximal part of the right
femur as well as at the right and left trochanter major, local anomalies in the bone are
visible, which falsely are predicted as lesion, but do not progress to lesions in the future
scan.
4. Conclusion
In this work we presented an asymmetric cascade network for the prediction of future focal
bone lesion evolution for marking and assessing high risk bone regions. It consists of a slice-
based Bone Net for the detection of bone in wbMRI and a subsequent patch-based Lesion
Net for lesion prediction. This is the first attempt which is capable of predicting lesions
on full volumetric wbMRI and demonstrated feasible results. We observed that anomalous
bone regions are the main triggers for false positives predictions, which do not progress to
lesions. In the future we plan to extend the approach by incorporating additional modalities
to assess infiltration patterns during multiple myeloma progression.
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